Epigenetics Antibodies Enhance Cancer Research

Rockland now manufacturers antibodies from the Epi-Plus® epigenetics line that can assist in various types of cancer research. Epigenetic alterations are extremely important to a cell’s transformation to cancer, and the mechanisms of epigenetic silencing of tumor suppressor genes and activation of oncogenes holds great promise for cancer prevention, detection, and therapy. Rockland epigenetic antibodies are developed under the most stringent of quality standards to ensure repeatable, accurate results. To learn more, visit www.rockland-inc.com/epigenetic_antibodies.aspx

This message has been sent and is copyright protected by Rockland Inc. 2013. All rights reserved.